LeadIQ logo
Learn more at LeadIQ.com
TransCode Therapeutics, Inc. logo

TransCode Therapeutics, Inc. Employee Directory

Biotechnology ResearchMassachusetts, United States11-50 Employees

TransCode Therapeutics, Inc. is a biotechnology research company based in Newton, Massachusetts, with 11 to 50 employees and a website at transcodetherapeutics.com. Its core approach uses a proprietary delivery platform called TTX to transport targeted therapeutics to cancer cells, with the lead candidate TTX-MC138 designed to target microRNA-10b, described as a master regulator of metastatic cell viability across multiple cancers. TransCode positions itself as a clinical-stage oncology company pursuing RNA and immuno-oncology therapeutics and maintains a rapidly expanding platform of drug candidates for various tumor indications. The company has licensed three oncolytic adenovirus candidates—UIO-524, UIO-525, and UIO-526—from Unleash Immuno Oncolytics, and has entered into a sponsored research agreement with Michigan State University. Public information indicates the company trades on Nasdaq under the ticker RNAZ and appointed Anna Moore as Chair of its Scientific Advisory Board in April 2026.

Find TransCode Therapeutics, Inc. employees' phone numbers or email addresses

TransCode Therapeutics, Inc. Global Highlights

Location
Employees

North America
25

Minus sign iconPlus sign icon
  • United States Of America
    25

Europe
2

Minus sign iconPlus sign icon
  • Netherlands
    1
  • Belgium
    1

TransCode Therapeutics, Inc.'s Leadership

  • Chief Executive Officer at TransCode Therapeutics, Inc.
    Q. L.
    Chief Executive Officer
    Mobile Phone
  • Chief Financial Officer at TransCode Therapeutics, Inc.
    E. B.
    Chief Financial Officer
    Mobile Phone
  • Chief Scientific Officer at TransCode Therapeutics, Inc.
    Z. M.
    Chief Scientific Officer
    Mobile Phone
  • Chief Scientist at TransCode Therapeutics, Inc.
    P. L.
    Chief Scientist
    Mobile Phone
  • Vice President Of Clinical Operations at TransCode Therapeutics, Inc.
    S. D.
    Vice President Of Clinical Operations
    Mobile Phone
  • Co-Founder, Chief Executive Officer, Director at TransCode Therapeutics, Inc.
    M. D.
    Co-Founder, Chief Executive Officer, Director
    Mobile Phone
  • Co-Founder at TransCode Therapeutics, Inc.
    A. M.
    Co-Founder
    Mobile Phone
  • Vice President at TransCode Therapeutics, Inc.
    T. F.
    Vice President
    Mobile Phone

TransCode Therapeutics, Inc. Employee Metrics

100%
50%
0%
2026
2025
  • Biotechnology
  • Entrepreneurship
  • Administrative
  • Business Development
  • Other
  • Business
  • Consultant

Contact profiles from TransCode Therapeutics, Inc.

Name
Title
Contact
Location
Last Update
  • Co-Founder at TransCode Therapeutics, Inc.
    A. M.
    Co-Founder
    Mobile Phone
    Oct 16, 2024
  • Chief Financial Officer at TransCode Therapeutics, Inc.
    E. B.
    Chief Financial Officer
    Mobile Phone
    Oct 22, 2024
  • Co-Founder, Chief Executive Officer, Director at TransCode Therapeutics, Inc.
    M. D.
    Co-Founder, Chief Executive Officer, Director
    Mobile Phone
    Jun 01, 2026
  • Chief Executive Officer at TransCode Therapeutics, Inc.
    Q. L.
    Chief Executive Officer
    Mobile Phone
    Oct 18, 2024
  • Chief Scientific Officer at TransCode Therapeutics, Inc.
    Z. M.
    Chief Scientific Officer
    Mobile Phone
    Sep 04, 2026
  • Chief Scientist at TransCode Therapeutics, Inc.
    P. L.
    Chief Scientist
    Mobile Phone
    Mar 31, 2025
  • Vice President Of Clinical Operations at TransCode Therapeutics, Inc.
    S. D.
    Vice President Of Clinical Operations
    Mobile Phone
    Apr 27, 2026
  • Vice President at TransCode Therapeutics, Inc.
    T. F.
    Vice President
    Mobile Phone
    Sep 26, 2024
  • Independent Director at TransCode Therapeutics, Inc.
    E. M.
    Independent Director
    Mobile Phone
    Netherlands, North Holland
    Jul 23, 2026
  • Senior Development Officer at TransCode Therapeutics, Inc.
    M. J.
    Senior Development Officer
    Mobile Phone
    Belgium, Brussels
    Jul 23, 2026

Frequently Asked Questions

What is TransCode Therapeutics, Inc. known for?

Minus sign iconPlus sign iconTransCode Therapeutics, Inc. was founded in 2016 and operates in the Biotechnology Research industry. Explore TransCode Therapeutics, Inc.'s company overview page for more information.

What is TransCode Therapeutics, Inc.'s most common email format?

Minus sign iconPlus sign iconTransCode Therapeutics, Inc. employees' email format typically follows the pattern of First.Last@transcodetherapeutics.com. Trying to find reliable and up-to-date employee contact data? Find more TransCode Therapeutics, Inc. email formats with LeadIQ.

How many employees does TransCode Therapeutics, Inc. have currently?

Minus sign iconPlus sign iconTransCode Therapeutics, Inc. has approximately 16 employees as of August 2026. These team members are located across 2 continents, including North America and Europe.

Who are TransCode Therapeutics, Inc.'s key employees and leadership?

Minus sign iconPlus sign icon

As of August 2026, TransCode Therapeutics, Inc.'s key employees include:

  • Chief Executive Officer: Q. L.
  • Chief Financial Officer: E. B.
  • Chief Scientific Officer: Z. M.
  • Chief Scientist: P. L.
  • Vice President Of Clinical Operations: S. D.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

  • B2B data verified in real-time
  • Sync data to your CRM, & add it to an outreach sequence in one click
  • Integrations with your tech stack for optimal efficiency
  • A patented AI cold email generator
  • Account & contact-level job change tracking

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.